XT
ANTX icon

XTX Topco’s AN2 Therapeutics ANTX Stock Holding History

XTX Topco’s Portfolio ANTX Stock Details ANTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.6K Buy
+22,402
New +$46.2K ﹤0.01% 3188
2025
Q4 		– Sell
-18,541
Closed -$23.5K – 3286
2025
Q3 		$23.5K Sell
18,541
-7,503
-29% -$8.58K ﹤0.01% 2298
2025
Q2 		$27.6K Buy
+26,044
New +$31K ﹤0.01% 2122
2025
Q1 		– Sell
-34,179
Closed -$47.2K – 2376
2024
Q4 		$47.2K Buy
34,179
+10,520
+44% +$12.8K ﹤0.01% 1902
2024
Q3 		$25.3K Buy
+23,659
New +$41.1K ﹤0.01% 1803
2024
Q2 		– Sell
-38,666
Closed -$126K – 1835
2024
Q1 		$126K Buy
+38,666
New +$421K 0.02% 1313

Other funds holding ANTX

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

XTX Topco's ANTX Position: Q1 2026 in Review

XTX Topco opened a new position in AN2 Therapeutics (ANTX) in Q1 2026: 22,402 shares worth $76.6K. The stake represents ﹤0.01% of the portfolio and ranks #3188 among its holdings. This is a return to the name: XTX Topco previously reported a position in ANTX as recently as Q3 2025.

XTX Topco first reported a position in ANTX in Q1 2024 and has held it in 6 quarters since. The position peaked at $126K in Q1 2024. 52 funds tracked by Wall St. Rank hold ANTX as of Q1 2026.

  • XTX Topco held 22,402 shares of AN2 Therapeutics worth $76.6K as of Q1 2026.
  • AN2 Therapeutics was a new XTX Topco position in Q1 2026.
  • AN2 Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3188 holding.
  • XTX Topco first reported a position in AN2 Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • XTX Topco's AN2 Therapeutics position peaked at $126K in Q1 2024.
  • 52 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.